Cost effective idenification of Mycobacteria isolated from blood. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Cost effective idenification of Mycobacteria isolated from blood.

Abstr Annu Meet Am Soc Microbiol. 1991 May 5-9;91:148 (abstract no. U-35). Unique Identifier : AIDSLINE ASM91/0070292
Kaminski DA; Weymouth LA; Casiano-Colon AE; Univ. of Rochester Med. Ctr., Rochester, NY.


Abstract: Mycobacterium avium complex (MAC) is a common cause of disseminated infection and mycobacteremia in AIDS patients. A total of 994 blood specimens in Dupont Isolator tubes were received in our laboratory for mycobacterial culture during one year (8/89-7/90). 127 cultures (12.8%) from 26 patients were positive for mycobacteria. We examined mycobacterial culture results from these 26 patients during the one year period to identify methods of modifying laboratory procedures in a cost effective manner. From the 26 mycobacteremic patients, acid fast bacilli (AFB) were isolated from 51% (127/250) of blood and 51% (75/146) of other specimen types. 88% (23/26) of blood isolates were identified as MAC. The other 3 patient isolates were: 1 M. tuberculosis, 1 M. kansasii, and 1 dual infection with both M. tuberculosis and a slow-growing atypical mycobacterium currently being identified at CDC. The mixed blood infection was easily recognized by differences in colony morphology on the primary media. After the first blood culture in which MAC was isolated, a total of 148 subsequent blood cultures were received from the 23 MAC bacteremic patients (median 6 per patient; range 0-23 per patient). These were submitted over a median of 80 days (range 0-321) after the first MAC positive blood culture. 62% of these subsequent blood cultures (92/148) were positive; all isolates were identified as MAC. Once MAC has been isolated from one blood culture, there is a high probability that a mycobacterium isolated from subsequent blood cultures in the same patient will also be MAC. For subsequent AFB blood isolates in MAC bacteremic patients, our current abbreviated identification scheme (acid fast smear, colony morphology, and 2 key biochemical tests) saves technical time and reagents. Further abbreviation (smear and colony morphology only) and a final report of presumptive MAC would save additional technical costs and decrease reporting time by at least 10-14 days.
Keywords: Blood/*MICROBIOLOGY Human Microbiological Techniques/ECONOMICS Mycobacterium avium Complex/*ISOLATION & PURIF ABSTRACTKWDblood/KWDmicrobiologyhumanmicrobiologicaltechniques/economicsmycobacteriumaviumcomplex/KWDisolation&purifabstract
920830
M9281076

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .